You have 9 free searches left this month | for more free features.

City

Shanghai (1)

Condition

Hepatocellular Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Shen Feng (1)

Collaborator

Intervention

anlotinib;toripalimab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

anlotinib;toripalimab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatocellular Cancer Trial in Shanghai (Anlotinib;Toripalimab)

Recruiting

Hepatocellular Cancer

Anlotinib;Toripalimab

Shanghai, Shanghai, China

Eastern hepatobilliary surgery hospital

Jul 7, 2022